| 910 |
increased |
glutathione binding
(GO:0043295)
|
glutathione conjugate
(CHEBI:24335)
|
2131: Conjugation, GSH
|
| 909 |
occurrence |
viral entry into host cell
(GO:0046718)
|
viral protein
(PR:000036197)
|
1738: SARS-CoV-2 cell entry
|
| 908 |
occurrence |
viral entry into host cell
(GO:0046718)
|
viral genome
(GO:0019015)
|
1738: SARS-CoV-2 cell entry
|
| 907 |
decreased |
second-messenger-mediated signaling
(GO:0019932)
|
sonic hedgehog protein
(PR:000014841)
|
2043: Decrease, Sonic Hedgehog second messenger production
|
| 906 |
decreased |
|
sonic hedgehog protein
(PR:000014841)
|
None
|
| 905 |
increased |
endocrine signaling
(GO:0038002)
|
estrone
(CHEBI:17263)
|
2092: Promotion, Ovarian Cancer
|
| 904 |
increased |
|
goblet cell
(CL:0000160)
|
2117: Increase, goblet cell number
|
| 903 |
decreased |
T cell activation involved in immune response
(GO:0002286)
|
T cell
(CL:0000084)
|
1702: Suppression of T cell activation
|
| 902 |
increased |
eye opacity
(MP:0009859)
|
Lens
(FMA:58241)
|
2083: Occurrence of Cataracts
|
| 901 |
functional change |
nitric oxide homeostasis
(GO:0033484)
|
endothelium
(UBERON:0001986)
|
2067: Altered, Nitric Oxide Levels
|
| 900 |
occurrence |
blood vessel remodeling
(GO:0001974)
|
blood vessel
(UBERON:0001981)
|
2069: Occurrence, Abnormal Vascular Remodeling
|
| 899 |
occurrence |
|
Blood vessel
(FMA:63183)
|
None
|
| 898 |
decreased |
decreased triiodothyronine level
(MP:0005473)
|
3,3',5'-triiodothyronine
(CHEBI:28774)
|
1003: Decreased, Triiodothyronine (T3)
|
| 897 |
decreased |
protein localization to cilium
(GO:0061512)
|
smoothened
(PR:000015288)
|
2044: Decrease, Smoothend relocation and activation
|
| 896 |
decreased |
second-messenger-mediated signaling
(GO:0019932)
|
|
None
|
| 895 |
increased |
cleft upper lip
(MP:0005170)
|
|
2042: Increase, Orofacial clefting
|
| 894 |
increased |
Cleft palate
(HP:0000175)
|
|
2042: Increase, Orofacial clefting
|
| 893 |
decreased |
abnormal palatal shelf fusion at midline
(MP:0009887)
|
secondary palate
(UBERON:0001716)
|
None
|
| 892 |
decreased |
palatal shelves fail to meet at midline
(MP:0009888)
|
primary palate
(UBERON:0005620)
|
None
|
| 891 |
decreased |
|
secondary palatal shelf
(UBERON:0005619)
|
None
|
| 890 |
decreased |
gene expression
(GO:0010467)
|
zinc finger protein GLI2
(PR:000008027)
|
2040: Decrease, GLI1/2 target gene expression
|
| 889 |
decreased |
gene expression
(GO:0010467)
|
zinc finger protein GLI1
(PR:000008026)
|
2040: Decrease, GLI1/2 target gene expression
|
| 888 |
decreased |
gene expression
(GO:0010467)
|
|
2 Events
|
| 887 |
increased |
gene expression
(GO:0010467)
|
|
2 Events
|
| 886 |
decreased |
protein import into nucleus, translocation
(GO:0000060)
|
zinc finger protein GLI2
(PR:000008027)
|
2028: Decrease, GLI1/2 translocation to nucleus
|